T. Schaeverbeke

1.1k total citations
32 papers, 744 citations indexed

About

T. Schaeverbeke is a scholar working on Rheumatology, Pharmacology and Epidemiology. According to data from OpenAlex, T. Schaeverbeke has authored 32 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 6 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in T. Schaeverbeke's work include Rheumatoid Arthritis Research and Therapies (8 papers), Inflammatory mediators and NSAID effects (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). T. Schaeverbeke is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Inflammatory mediators and NSAID effects (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). T. Schaeverbeke collaborates with scholars based in France, Italy and Canada. T. Schaeverbeke's co-authors include J. C. Le Huec, J Dehais, A Le Rebeller, Jean Faber, D Clément, B Bannwarth, Christophe Richez, F. Demotes‐Mainard, Laurence Labat and Jean Sibilia and has published in prestigious journals such as Biomaterials, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

T. Schaeverbeke

32 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Schaeverbeke France 12 233 223 177 124 90 32 744
Francis Y. Lee United States 20 248 1.1× 475 2.1× 174 1.0× 128 1.0× 66 0.7× 43 1.3k
Masato Yuasa Japan 21 166 0.7× 652 2.9× 269 1.5× 110 0.9× 46 0.5× 65 1.3k
Terhi J. Heino Finland 18 102 0.4× 197 0.9× 279 1.6× 69 0.6× 87 1.0× 43 1.2k
Zakareya Gamie United Kingdom 17 156 0.7× 350 1.6× 99 0.6× 74 0.6× 45 0.5× 42 832
Tiao Lin China 23 129 0.6× 590 2.6× 137 0.8× 288 2.3× 44 0.5× 46 1.3k
Katie J. Welldon Australia 15 173 0.7× 328 1.5× 253 1.4× 61 0.5× 42 0.5× 17 1.4k
Ko Kato Japan 20 193 0.8× 425 1.9× 156 0.9× 66 0.5× 21 0.2× 63 1.2k
Arkady Rutkovskiy Norway 14 82 0.4× 199 0.9× 243 1.4× 115 0.9× 40 0.4× 24 1.1k
Qinglin Kang China 21 112 0.5× 379 1.7× 219 1.2× 231 1.9× 29 0.3× 75 1.1k
Konttinen Yt Finland 21 149 0.6× 921 4.1× 126 0.7× 89 0.7× 36 0.4× 44 1.4k

Countries citing papers authored by T. Schaeverbeke

Since Specialization
Citations

This map shows the geographic impact of T. Schaeverbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Schaeverbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Schaeverbeke more than expected).

Fields of papers citing papers by T. Schaeverbeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Schaeverbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Schaeverbeke. The network helps show where T. Schaeverbeke may publish in the future.

Co-authorship network of co-authors of T. Schaeverbeke

This figure shows the co-authorship network connecting the top 25 collaborators of T. Schaeverbeke. A scholar is included among the top collaborators of T. Schaeverbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Schaeverbeke. T. Schaeverbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gouverneur, Amandine, Jérôme Avouac, Clément Prati, et al.. (2021). POS0225 RISK OF MAJOR CARDIOVASCULAR EVENT ACROSS JAK INHIBITOR TREATED PATIENTS: ANALYSIS OF A NATIONAL CLAIM DATABASE. Annals of the Rheumatic Diseases. 80. 331–332. 4 indexed citations
2.
Cantagrel, Alain, B. Combe, Maxime Dougados, et al.. (2013). FRI0245 Prospective follow-up of tocilizumab treatment in 1100 patients with refractory rheumatoid arthritis: tolerance data from the french registry regate (registry –roactemra). Annals of the Rheumatic Diseases. 72. A456–A457. 2 indexed citations
3.
Pierreisnard, A., H. Gin, T. Schaeverbeke, et al.. (2012). P223 Effets métaboliques d’un inhibiteur du récepteur de l’Interleukine-6 dans la polyarthrite rhumatoïde : étude prospective.. Diabetes & Metabolism. 38. A83–A83. 1 indexed citations
4.
Kostine, Marie, Thomas Barnetche, Emilie Rabois, et al.. (2012). FRI0192 Is early neutropenia associated with clinical response in patients receiving tocilizumab in rheumatoid arthritis?. Annals of the Rheumatic Diseases. 71. 377–377. 2 indexed citations
5.
Terrier, Benjamin, David Launay, G. Kaplanski, et al.. (2010). Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry. Arthritis Care & Research. 62(12). 1787–1795. 75 indexed citations
6.
7.
Dumoulin, Chantale, et al.. (2005). Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials.. PubMed. 23(1). 80–4. 16 indexed citations
8.
Richez, Christophe, et al.. (2004). Successful treatment of relapsing polychondritis with infliximab.. PubMed. 22(5). 629–31. 26 indexed citations
9.
Bannwarth, B, Philippe Bertin, Fabienne Péhourcq, et al.. (2001). Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-b-cyclodextrin. International Journal of Clinical Pharmacology and Therapeutics. 39(1). 33–36. 11 indexed citations
10.
Schaeverbeke, T., et al.. (1999). Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case.. PubMed. 66(3). 177–9. 11 indexed citations
11.
Huec, J. C. Le, et al.. (1996). Traumatic tear of the rotator interval. Journal of Shoulder and Elbow Surgery. 5(1). 41–46. 53 indexed citations
12.
Sibilia, Jean, Anne Durandy, T. Schaeverbeke, & Jean‐Paul Fermand. (1996). HYPER-IgM SYNDROME ASSOCIATED WITH RHEUMATOID ARTHRITLS: REPORT OF RA IN A PATIENT WITH PRIMARY IMPAIRED CD 40 PATHWAY. Lara D. Veeken. 35(3). 282–284. 11 indexed citations
13.
Huec, J. C. Le, T. Schaeverbeke, D Clément, Jean Faber, & A Le Rebeller. (1995). Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials. 16(2). 113–118. 206 indexed citations
14.
Bannwarth, B, F. Lapicque, Fabienne Péhourcq, et al.. (1995). Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid.. British Journal of Clinical Pharmacology. 40(3). 266–269. 50 indexed citations
15.
Bannwarth, B, F. Demotes‐Mainard, T. Schaeverbeke, Laurence Labat, & J Dehais. (1995). Central analgesic effects of aspirin‐like drugs. Fundamental and Clinical Pharmacology. 9(1). 1–7. 57 indexed citations
16.
Huec, J. C. Le, et al.. (1994). Isolated avulsion fracture of the lesser tubercle of the humerus in children.. PubMed. 60(4). 427–9. 27 indexed citations
17.
Bannwarth, B, F. Demotes‐Mainard, T. Schaeverbeke, & J Dehais. (1993). Where are peripheral analgesics acting?. Annals of the Rheumatic Diseases. 52(1). 1–4. 20 indexed citations
18.
Schaeverbeke, T., et al.. (1993). [Systemic scleroderma and hairy cell leukemia. A new case].. PubMed. 60(5). 371–2. 2 indexed citations
19.
Bannwarth, B, et al.. (1992). [Mode of action of non-narcotic analgesics].. PubMed. 59(4). 267–70. 2 indexed citations
20.
Lifermann, François, et al.. (1992). [Deforming arthropathy associated with the presence of anti Jo-1 antibody in polymyositis. A new case].. PubMed. 21(30). 1423–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Y. Lee Breakdown of academic impact, for papers by Masato Yuasa Breakdown of academic impact, for papers by Terhi J. Heino Breakdown of academic impact, for papers by Zakareya Gamie Breakdown of academic impact, for papers by Tiao Lin Breakdown of academic impact, for papers by Katie J. Welldon Breakdown of academic impact, for papers by Ko Kato Breakdown of academic impact, for papers by Arkady Rutkovskiy Breakdown of academic impact, for papers by Qinglin Kang Breakdown of academic impact, for papers by Konttinen Yt
Rankless by CCL
2026